세계의 단백질체학 시장 예측(2025-2030년)

The global proteomics market is expected to grow from USD 36.720 billion in 2025 to USD 57.582 billion in 2030, at a CAGR of 9.42%.

The global proteomics market is experiencing significant growth, driven by the increasing importance of studying proteins and their roles in biological processes. Proteomics, the comprehensive study of an organism's protein dataset, encompasses their structure, functions, and interactions, which vary across cells and over time. This field provides critical insights into protein interactions, localization, and involvement in biological processes, making it essential for advancing medical and biological research. The market is propelled by technological advancements and rising demand for personalized medicine, though challenges such as high costs and a shortage of skilled professionals may hinder growth. Despite these obstacles, the market is poised for expansion, particularly in regions with advanced healthcare infrastructure and strong research funding.

Key Growth Drivers

Technological Advancements

Advancements in technologies such as mass spectrometry (MS), including dual mass analyzers like LC/MS, GC/MS, FT-MS, and MALDI-TOF/TOF, are major drivers of the proteomics market. These innovations enable detailed analysis of protein structures, allowing thousands of proteins to be resolved in a single gel. Improvements in protein fractionation techniques and bioinformatics further enhance the ability to process complex proteomic data, driving adoption in research and clinical applications. Increased investments in research and development are also accelerating the development of cutting-edge proteomic tools, supporting market growth.

Rising Demand for Personalized Medicine

The growing focus on personalized medicine, which tailors treatments to individual patient profiles, is boosting demand for proteomics. By providing insights into protein expression and interactions, proteomics enables the development of targeted therapies, particularly for diseases like cancer. This demand is further supported by increased funding for proteomic research, which aims to identify biomarkers and therapeutic targets, driving market expansion as healthcare systems prioritize precision medicine.

Market Segmentation

By Geography

The proteomics market is segmented into North America, South America, Europe, the Middle East and Africa, and Asia-Pacific. North America is expected to hold a significant market share, driven by its rapid adoption of advanced technologies and robust healthcare infrastructure. The region's focus on personalized medicine and substantial investments in research further support market growth. Asia-Pacific is projected to be the fastest-growing region, fueled by rising government funding for proteomics research and increasing interest in precision medicine in countries like China and India, where healthcare systems are expanding rapidly.

Competitive Landscape

Key players, including Proteomics International, Biognosys AG, and Creative Proteomics (a division of Creative Dynamics Inc.), are driving innovation in the proteomics market. These companies focus on developing advanced proteomic technologies and services, enhancing data analysis capabilities, and supporting applications in personalized medicine and biological research, strengthening their market positions.

The global proteomics market is set for robust growth, propelled by advancements in technologies like mass spectrometry and the rising demand for personalized medicine. North America leads due to its advanced infrastructure and research investments, while Asia-Pacific's rapid growth reflects increased funding and healthcare advancements. Despite challenges like high costs and a lack of skilled professionals, the market's trajectory remains positive, driven by the critical role of proteomics in understanding biological processes and developing targeted therapies, supported by ongoing innovation from leading industry players.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2020 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Technology

• Microarrays
• Spectroscopy
• X-Ray Crystallography
• Chromatography
• Others

By Component

• Reagents & Kits
• Consumables
• Others

By Reagents

• Microarrays Reagents
• Spectroscopy Reagents
• X-Ray Crystallography Reagents
• Chromatography Reagents
• Other Reagents

By Application

• Discovery of Protein Biomarkers
• Study of Tumor Metastasis
• Neurotrauma and Neurology
• Renal Disease Diagnosis
• Fetal and Maternal Medicine
• Others

By Geography

• NorthAmerica
• United States
• Canada
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Others
• Middle East and Africa
• Israel
• UAE
• Saudi Arabia
• Others
• Asia Pacific
• China
• India
• Australia
• South Korea
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL PROTEOMICS MARKET BY TECHNOLOGY

• 5.1. Introduction
• 5.2. Microarrays
• 5.3. Spectroscopy
• 5.4. X-Ray Crystallography
• 5.5. Chromatography
• 5.6. Others

6. GLOBAL PROTEOMICS MARKET BY COMPONENT

• 6.1. Introduction
• 6.2. Reagents & Kits
• 6.3. Consumables
• 6.4. Others

7. GLOBAL PROTEOMICS MARKET BY REAGENTS

• 7.1. Introduction
• 7.2. Microarrays Reagents
• 7.3. Spectroscopy Reagents
• 7.4. X-Ray Crystallography Reagents
• 7.5. Chromatography Reagents
• 7.6. Other Reagents

8. GLOBAL PROTEOMICS MARKET BY APPLICATION

• 8.1. Introduction
• 8.2. Discovery of Protein Biomarkers
• 8.3. Study of Tumor Metastasis
• 8.4. Neurotrauma and Neurology
• 8.5. Renal Disease Diagnosis
• 8.6. Fetal and Maternal Medicine
• 8.7. Others

9. GLOBAL PROTEOMICS MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. United States
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. South America
  • 9.3.1. Brazil
  • 9.3.2. Argentina
  • 9.3.3. Others
• 9.4. Europe
  • 9.4.1. Germany
  • 9.4.2. France
  • 9.4.3. United Kingdom
  • 9.4.4. Others
• 9.5. Middle East & Africa
  • 9.5.1. Saudi Arabia
  • 9.5.2. UAE
  • 9.5.3. Others
• 9.6. Asia Pacific
  • 9.6.1. China
  • 9.6.2. Japan
  • 9.6.3. South Korea
  • 9.6.4. India
  • 9.6.5. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. Biognosys AG
• 11.2. Creative Proteomics (Division of Creative Dynamics Inc)
• 11.3. Proteomics International
• 11.4. MRM Proteomics
• 11.5. Evotec AG
• 11.6. Proteome Factory
• 11.7. DC Biosciences
• 11.8. AYOXXA Biosystems GmbH
• 11.9. VProteomics
• 11.10. Thermo Fisher Scientific
• 11.11. Agilent Technologies

12. APPENDIX

• 12.1. Currency
• 12.2. Assumptions
• 12.3. Base and Forecast Years Timeline
• 12.4. Key Benefits for the Stakeholders
• 12.5. Research Methodology
• 12.6. Abbreviations